TGT
50
-3
WEC
62
2
EA
55
-2
TRV
36
3
INTC
56
4
ROP
59
5
WHR
68
-4
CMCSA
41
-9
GT
41
2
CRM
59
5
PYPL
74
2
SWK
46
-3
MMC
64
3
FFIV
67
3
NAVI
61
3
ORCL
67
2
KO
54
2
LH
55
3
GIS
47
-2
FRT
50
5
TGT
50
-3
WEC
62
2
EA
55
-2
TRV
36
3
INTC
56
4
ROP
59
5
WHR
68
-4
CMCSA
41
-9
GT
41
2
CRM
59
5
PYPL
74
2
SWK
46
-3
MMC
64
3
FFIV
67
3
NAVI
61
3
ORCL
67
2
KO
54
2
LH
55
3
GIS
47
-2
FRT
50
5
Financhill
Back

Microsoft Vs. Blueprint Medicines Sector Stock Comparison

Buy
64

MSFT
Microsoft

Last Price:
$498.75
Seasonality Move:
1.94%
Sell
50

BPMC
Blueprint Medicines

Last Price:
$128.39
Seasonality Move:
6.28%
Buy
64
Microsoft (MSFT) is a Buy

Is Microsoft a Buy, Sell or Hold?

  • The current Microsoft [MSFT] share price is $498.84. The Score for MSFT is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • MSFT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $128.35. The Score for BPMC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MSFT Stock Price Chart

What is Microsoft's stock price today?

  • The Microsoft share price today is $498.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MSFT is experiencing buying pressure, which is a positive indicator for future bullish movement.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $128.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing slight buying pressure.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 11.8 Buy
Relative Strength Index (14 RSI): 72.77 Buy
Chaikin Money Flow: 8591577 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (466.34 - 491.42) Buy
Bollinger Bands (100): (380.92 - 463.86) Buy

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.65 Buy
Relative Strength Index (14 RSI): 74.59 Buy
Chaikin Money Flow: 675123 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119 - 133.06) Buy
Bollinger Bands (100): (84.56 - 117) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 494.4 Buy
20-day SMA: 483.21 Buy
50-day SMA: 455.96 Buy
200-day SMA: 424.43 Buy
8-day EMA: 492.7 Buy
20-day EMA: 483.05 Buy
50-day EMA: 459.65 Buy
200-day EMA: 427.59 Buy

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 128.23 Buy
20-day SMA: 128.14 Buy
50-day SMA: 111.57 Buy
200-day SMA: 97.6 Buy
8-day EMA: 128.16 Buy
20-day EMA: 125.23 Buy
50-day EMA: 115.07 Buy
200-day EMA: 100.77 Buy

Microsoft Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.60 per share, an increase next quarter of $0.06 per share, an increase this year of $1.57 per share, and an increase next year of $1.72 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.67 per share, an increase next quarter of $0.33 per share, an increase this year of $0.60 per share, and an increase next year of $1.50 per share.

Microsoft Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):